The three-building facility enables JN to expand its ability to increase vaccine supplies. The move is intended to help reduce time to market for the company's Meningococcal meningitis serotypes A, C, Y and W-135.
Companies in this press-release
JN-Intl. acquires vaccine facilities from Pfizer
Biopharmaceutical firm JN Intl.acquired Biocor, a subsidiary of Pfizer, Inc.
Jun 2, 2009
Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Downloads
